Profluent, which wants to use AI for protein design in drug discovery, raised $106M led by Bezos Expeditions and Altimeter, bringing its total funding to $150M (Amy Feldman/Forbes)

• Profluent has successfully secured $106 million in funding, with contributions from Bezos Expeditions and Altimeter, increasing its total funding to $150 million to advance its AI-driven protein design initiatives in drug discovery and agriculture.
• This significant funding will enable Profluent to scale its AI models, potentially transforming the landscape of drug development and agricultural practices by making protein design more efficient and programmable.
• The rise of AI-driven startups in various sectors, including workplace automation and financial management, highlights a growing trend where technology is increasingly integrated into traditional industries, reflecting a broader shift towards innovation and efficiency.

— via World Pulse Now AI Editorial System